Literature DB >> 8405004

Physiological modelling of renal drug clearance.

I Janků1.   

Abstract

A physiological model of renal drug clearance is presented with the aim of establishing a basis for adjusting drug dosing regimens in renal insufficiency. In agreement with the morphology of blood supply to the nephron, the model assumes serial arrangement of the processes involved in drug excretion. Fractional extraction by filtration in the glomeruli is defined in terms of the product of the unbound fraction of the drug, the filtration fraction being responsible for the limited extraction efficiency of this process. For a description of the limitations of the tubular secretory process by plasma flow through peritubular capillaries, the parallel tube model is utilized. The assumption of direct proportionality between the transport maximum of the secretory process and filtrate flow in the tubules permits a quantitative comparison of the intrinsic tubular secretion clearance and the effectiveness of the filtration process. Provided that the secretory mechanism is highly effective, renal clearance becomes dependent only on kidney plasma flow and the fraction of drug not reabsorbed in the tubules. Tubular reabsorption results only in a proportional decrease in renal clearance. The model predicts proportionality of renal drug clearance to GFR, which as a rule is used for dosage adjustment of drugs in renal insufficiency, only for compounds exclusively excreted by filtration. Compounds also excreted by tubular secretion in general exhibit a curvilinear relationship. The curvature is less pronounced as an increasing fraction of the drug is protein bound in blood. Therefore, for dosage adjustment of drugs secreted in the tubules and highly bound in blood, proportionality between renal clearance and GFR can serve as a reasonable approximation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405004     DOI: 10.1007/bf02440850

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

1.  Pharmacokinetic analysis of renal handling of sulfamethizole.

Authors:  R Hori; K Sunayashiki; A Kamiya
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

2.  Plasma protein binding of drugs and adjustment of their dosing regimen in patients with chronic renal failure.

Authors:  O Schück
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1987-09

Review 3.  Interrelationship between renal haemodynamics, drug kinetics and drug action.

Authors:  K L Duchin; R W Schrier
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

4.  Relationship between renal clearance of drugs and glomerular filtration rate in patients with chronic renal insufficiency.

Authors:  O Schück; H Nádvorníková; J Grafnetterová; V Reitschlägerová
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1985-04

5.  Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney.

Authors:  S Hall; M Rowland
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

Review 6.  Physiologically based models and strategic experiments in hepatic pharmacology.

Authors:  L Bass; S Keiding
Journal:  Biochem Pharmacol       Date:  1988-04-15       Impact factor: 5.858

7.  Pharmacokinetics and clearances related to renal processes.

Authors:  E R Garrett
Journal:  Int J Clin Pharmacol Biopharm       Date:  1978-04

8.  Effect of plasma protein binding on renal clearance of drugs.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1980-04       Impact factor: 3.534

9.  Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.

Authors:  K Turnheim
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 10.  Renal failure, drug pharmacokinetics and drug action.

Authors:  J Fabre; L Balant
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

View more
  7 in total

1.  Predicting tubular reabsorption with a human kidney proximal tubule tissue-on-a-chip and physiologically-based modeling.

Authors:  Courtney Sakolish; Zunwei Chen; Chimeddulam Dalaijamts; Kusumica Mitra; Yina Liu; Tracy Fulton; Terry L Wade; Edward J Kelly; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol In Vitro       Date:  2019-12-17       Impact factor: 3.500

2.  Physiological modeling for indirect evaluation of drug tissular pharmacokinetics under non-steady-state conditions: an example of antimicrobial prophylaxis during liver surgery.

Authors:  Franck Lagneau; Jean Marty; Pascale Beyne; Michel Tod
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

3.  Quantitative analysis of drug handling by the kidney using a physiological model of renal drug clearance.

Authors:  I Janků; K Zvára
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Aleksandra Galetin; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-08-09       Impact factor: 4.009

5.  Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.

Authors:  Ruben Poesen; Liesbeth Viaene; Kristin Verbeke; Kathleen Claes; Bert Bammens; Ben Sprangers; Maarten Naesens; Yves Vanrenterghem; Dirk Kuypers; Pieter Evenepoel; Björn Meijers
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

6.  Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery.

Authors:  Mohammed H Elkomy; Pervez Sultan; David R Drover; Ekaterina Epshtein; Jeffery L Galinkin; Brendan Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

7.  An Improved Vascularized, Dual-Channel Microphysiological System Facilitates Modeling of Proximal Tubular Solute Secretion.

Authors:  Alenka Chapron; Brian D Chapron; Dale W Hailey; Shih-Yu Chang; Tomoki Imaoka; Kenneth E Thummel; Edward Kelly; Jonathan Himmelfarb; Danny Shen; Catherine K Yeung
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.